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ABSTRACT
CONTEXT AND OBJECTIVE: Carotid body tumors, or chemodectomas, are the most common head and 
neck paragangliomas, accounting for 80% of the cases. They may present minor symptoms; however, they 
deserve special attention in order to achieve accurate diagnosis and adequate treatment. The objectives 
of this study were to show the approach towards chemodectomas and evaluate the complications of the 
patients treated surgically without previous embolization.
DESIGN AND SETTING: Retrospective study on chemodectomas followed up at the Head and Neck 
Surgery Service, Department of Surgery, Unicamp. 
METHODS: Twenty-two patients were evaluated between 1983 and 2009. The diagnosis was based on 
clinical findings and imaging methods. The epidemiological characteristics, lesion characteristics, diagnos-
tic methods, treatment and complications were analyzed.
RESULTS: The paragangliomas were classified as Shamblin I (9%), II (68.1%) and III (22.7%). Angiography, 
magnetic resonance imaging and computed tomography confirmed the diagnosis in 20 patients (90.9%). 
Five (22.7%) had significant bleeding during the surgery, while four (18.1%) had minor bleeding. Four 
patients (18.1%) developed neurological sequelae. Seven (31.8%) needed ligatures of the external carotid 
artery. Three patients (13.6%) underwent carotid bulb resection. The postoperative follow-up ranged from 
3 months to 14 years without recurrences or mortality. 
CONCLUSIONS: In our experience and in accordance with the literature, significant bleeding and neuro-
logical sequelae may occur in chemodectoma cases, particularly in Shamblin III patients. The complica-
tions from treatment without previous embolization were similar to data in the literature data, from cases 
in which this procedure was applied prior to surgery.
RESUMO
CONTEXTO E OBJETIVO: O tumor de corpo carotídeo, ou quimiodectoma, é o paraganglioma mais co-
mum em cabeça e pescoço, com aproximadamente 80% dos casos. Pode apresentar poucos sintomas; 
no entanto, necessita atenção especial para o diagnóstico e tratamento adequado. Os objetivos deste 
estudo são mostrar a abordagem do quimiodectoma e avaliar as complicações nos pacientes tratados 
cirurgicamente sem embolização prévia.
TIPO DE ESTUDO E LOCAL: Estudo retrospectivo de quimiodectomas acompanhados pelo Serviço de 
Cirurgia de Cabeça e Pescoço, Departamento de Cirurgia, Unicamp.
MÉTODOS: Vinte e dois pacientes foram avaliados entre 1983 e 2009. O diagnóstico foi baseado em acha-
dos clínicos e métodos de imagens. Foram analisados aspectos epidemiológicos, características das le-
sões, métodos diagnósticos, tratamento e complicações.
RESULTADOS: Os paragangliomas foram classificados em Shamblin I (9%), II (68,1%) e III (22,7%). Angio-
grafia, ressonância nuclear magnética e tomografia computadorizada confirmaram o diagnóstico em 
20 pacientes (90,9%). Cinco (22,7%) tiveram sangramento significativo durante a cirurgia, enquanto qua-
tro (18,1%) tiveram sangramento mínimo. Quatro pacientes (18,1%) tiveram sequelas neurológicas. Sete 
(31,8%) necessitaram de ligadura da artéria carótida externa. Três (13,6%) foram submetidos a ressecção do 
bulbo carotídeo. O acompanhamento variou de 3 meses a 14 anos, sem recorrências ou óbitos.
CONCLUSÕES: Em nossa experiência e de acordo com a literatura, sangramentos significativos e sequelas 
neurológicas podem ocorrer nos quimiodectomas principalmente em pacientes Shamblin III. As compli-
cações do tratamento sem embolização prévia foram similares aos relatos observados na literatura nos 
quais se aplicou tal procedimento antes da cirurgia.
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INTRODUCTION
Paragangliomas are tumors located along the human body’s sym-
pathetic and parasympathetic chains. They may grow along these 
fibers, and may be located in various parts of the body, such as 
the abdomen, chest, mediastinum, retroperitoneum and head 
and neck regions, but mostly associated with adrenal gland. 
The head and neck region is the most common site of extra-adre-
nal paragangliomas, accounting for approximately 70% of  the 
cases, and the carotid body is responsible for the majority of 
these cases.  Because of their location and vascularization, they 
can pose a great technical challenge for surgeons.1
These tumors are often benign, presenting slow growth,2 and 
are located in the upper cervical region. There is no evidence of 
gender predominance. They may only present minor symptoms, 
commonly only a pulsatile mass in the neck. However, they can 
cause local discomfort, dysphagia, hoarseness, stridor, vertigo 
and paralysis of the cranial nerves, and sometimes attain large 
volumes (some authors have described tumors as large as 10 cm).1 
They can be divided into tumors with either sporadic or 
familial traits. In the sporadic type, bilaterality has been reported 
in 5 to 10% of the cases.3 The familial form is manifested through 
a dominant autosomal gene, and in these cases, bilaterality may 
reach up to 30%.4 Recent studies have described a mutation along 
germinative lines, which may explain the etiology, through iden-
tification of six specific genes (RET, VHL, NF1 and subunits of 
SDH).4 The hereditary form is mostly correlated with mutations 
in the SDHD gene.5,6 
The incidence in the general population is difficult to esti-
mate. However, according to Rodriguez-Cuevas,7 the incidence 
in the general population is about 0.01%. Since 1969, when 
Árias-Stella demonstrated carotid body enlargement in high-
altitude Peruvian populations (due to the low oxygen pressure), 
it has been known that chronic hypoxia is an important factor in 
the etiology of this neoplasm.8 The malignant potential is about 
6% and the criteria are based on cell atypia, mitosis, local inva-
sions and, especially, by the presence of metastasis.9-11 
The diagnosis is based on clinical history, physical examina-
tion, imaging methods (such as ultrasound, computed tomog-
raphy and magnetic resonance) and vascular evaluations 
(including angiography, tomographic angiography and mag-
netic resonance angiography).12,13 In this context, based on the 
Shamblin classification, Arya et al. used magnetic resonance 
imaging to pre-classify carotid body tumors before surgical 
treatment.14 This could improve preoperative management and 
reduce the complication rate.9
The best treatment for carotid body paragangliomas is a sur-
gical approach. The literature shows that patients may or may not 
undergo prior embolization. Some authors have justified using 
embolization because it reduces complications such as bleeding 
or neurological sequelae,15 although this procedure is not without 
its own inherent complications.16
OBJECTIVES 
The objectives of this study were to present an academic institu-
tion’s experience of dealing with carotid body paragangliomas, 
such as the diagnostic methods, complementary examinations 
and treatment, and to show the possible complications that may 
occur over the natural evolution of the disease or in relation to 
surgery without previous embolization.
METHODS
This was a retrospective study based on patients with carotid body 
tumors who were treated at the Head and Neck Surgery Service, 
Department of Surgery, Universidade Estadual de Campinas 
(Unicamp). This study was submitted to and approved by this 
institution’s Research Ethics Committee. Twenty-two patients 
with carotid body paragangliomas were evaluated between 1983 
and 2009. These patients were treated and followed up by the 
institution’s Head and Neck Surgery Service. The parameters ana-
lyzed were sex, age at the time of diagnosis, symptoms, presence 
of bilateral involvement, tumor size, diagnostic methods, treat-
ment and complications. The diagnosis was based on the clini-
cal findings, fine needle aspiration (FNA) and imaging methods, 
such as cervical ultrasonography, computed tomography (CT), 
magnetic resonance imaging (MRI) and angiography.
Bleeding was measured in our study and was classified as 
minimal (less than 200 ml), moderate (ranging from 200 to less 
than 1000 ml) and significant (over 1000 ml), according to the 
need for blood transfusion. Thus, when the bleeding was min-
imal, blood transfusion was not needed. In cases of moderate 
bleeding, one or two red blood cell units were infused. Finally, 
when the bleeding was significant, more than two red blood cell 
units were infused.
The tumors were divided by means of the Shamblin classifi-
cation,8 according to the involvement of the carotid wall and dif-
ficulty of surgical resection. Shamblin I was reserved for tumors 
that were relatively small and easy to resect, with minimal or no 
adherence to the carotid wall. Shamblin II consisted of tumors 
with partial involvement of the carotid wall, and Shamblin III 
completely involved the carotid bifurcation. 
All the patients underwent surgical treatment, without embo-
lization or prior radiotherapy. The resection was complete in all 
patients, with a sub-adventitial avascular approach (Figure 1).
RESULTS
Our study included two patients with Shamblin I (9%), 15 with 
Shamblin II (68.1%) and five with Shamblin III (22.7%). Fourteen 
patients (63.6%) were female. The patients’ ages ranged from 23 
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to 77 years (average of 43 years) and all of them had an asymp-
tomatic cervical mass at the initial presentation. The mass diam-
eter ranged from 3 to 8 centimeters (mean of 4.3 cm). Two cases 
(9%) were bilateral, without any other signs or symptoms. The 
length of history ranged from 8 months to 13 years (average of 
5 years), with the largest tumor occurring in the patient with 
the longest history. Six patients (27.2%) had undergone surgery 
for a biopsy or resection in other services, and all procedures 
were incomplete and interrupted because of excessive bleed-
ing. In our service, the diagnosis was suspected preoperatively 
in all patients, with two exceptions (9%). Consequently, 91% 
were managed with predefined surgical planning. Angiography 
was performed on 15 patients (68.1%), cervical CT scan on 11 
(50%), cervical ultrasonography on nine (40.9%), and MRI on 
five patients (22.7%) (Figures 2 to 4). The two unsuspected cases, 
which underwent ultrasonography, had a preoperative diagno-
sis of branchial cleft cyst and undefined adenopathy. These cases 
were classified subsequently as Shamblin II and did not have any 
postoperative sequelae or complications.
All the imaging methods with arterial evaluations (angiogra-
phy, CT and MRI) were diagnostic for the patients who under-
went these examinations, with no wrong preoperative diagnoses. 
Ultrasonography was performed on nine patients (40.9%), 
and was helpful in diagnosing seven cases (77.7%). However, 
this examination (particularly when there was no Doppler study) 
suggested the possibilities of branchial cyst and adenomegaly in 
two cases that had wrong preoperative diagnoses.
Fine needle aspiration (FNA) was performed on five patients 
(35.7%), and was suggestive of the diagnosis in four cases (80%). 
In one of the patients, who also underwent ultrasonography 
without a Doppler study, FNA erroneously diagnosed a bran-
chial cyst. 
During the surgical procedure, five patients (22.7%) pre-
sented significant bleeding (over 1000 ml). Three of these patients 
were Shamblin III and two were Shamblin II, and the former had 
incorrect preoperative diagnoses. 
Among the five Shamblin III patients, three (60%) had 
postoperative neurological sequelae. One patient had a sym-
pathetic chain deficit that evolved to Horner’s syndrome. The 
second had a vagus nerve deficit and evolved with hoarse-
ness and the third patient had a transient ischemic attack that 
resolved completely one day after the symptoms, without late 
neurological sequelae.
Twelve patients (54.5 %) had moderate bleeding (ranging 
from 200 to less than 1000 ml). Of these, nine patients (75%) 
were Shamblin II and three (25%) were Shamblin III. In this 
group, one patient (8.3%) who was classified as Shamblin II 
evolved with unilateral hypoglossal nerve deficit (close contact 
with the tumor). 
Figure 2. Computed tomography showing left parapharyngeal tumor 
(arrow).
Figure 1. Tumor mass dissected at the carotid bifurcation. (A) Arrow 
shows carotid body tumor. (B) Preserved carotid arteries (arrows) after 
resection of carotid body tumor. 
A
B
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In the five remaining patients (22.7%), the intraopera-
tive bleeding was considered to be minimal (up to 200  ml). 
These patients were all Shamblin I or II and none had 
neurological sequelae.
In nine of our patients (40.9%), some form of vascular pro-
cedure was needed. Seven patients (31.8%) needed external 
carotid ligation and three of these needed en-block resection of 
the carotid bulb. In two cases, there was a need for intralumi-
nal vascular shunts for arterial reconstruction. In such cases, 
the possibilities of distal clot formation and stroke need to be 
borne in mind, and in one of our patients, this was managed by 
using distal artery aspiration, with a flexible arterial catheter 
and a 10 ml syringe. Through this, the clot was removed with 
immediate reflux of the distal internal carotid artery, without 
sequelae. The vascular reconstruction was done using a saphe-
nous vein graft in one patient, and end-to-end anastomosis 
between the common and the internal carotid artery in the 
other two patients. Intraluminal shunt was used in these cases 
to prevent stroke. 
Graph 1 presents the intraoperative bleeding accord-
ing to the Shamblin classification, and shows the relation-
ship between  the  bleeding and higher Shamblin classification. 
Considering all the patients, the bleeding ranged from 50 ml to 
2,000 ml, with a mean of 667 milliliters.
In total, four patients (18.1%) had neurological sequelae 
(Graph 2). One developed Horner’s syndrome; one presented 
permanent deficits of the IX, X and XII cranial nerves; another 
had an isolated permanent XII nerve deficit; and the last had a 
transient ischemic attack.
Figure 4. Angiography showing vascular mass at the carotid 
bifurcation (arrow).
Figure 3. Magnetic resonance angiography with three-dimensional 
reconstruction, showing a vascular mass at the carotid bifurcation (arrow).
Graph 1. Intraoperative bleeding according to Shamblin 
classification. 
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Another important complication was intraoperative cardiac 
arrest due to the carotid bulb manipulation. This affected one 
patient and was managed immediately with external cardiac mas-
sage and infusion of adrenaline and atropine. The cardiac activity 
returned successfully less than one minute after the intercurrence, 
and the patient evolved without sequelae. 
Bilaterality was found in two patients (9%), which was man-
aged surgically in two different settings. One of these patients 
had an association with chronic hypoxia (severe cardiac valve 
disease, interventricular communication and a persistent arterial 
channel). He exhibited frequent hypotension during the postop-
erative period, possibly secondary to slow adaptation to hypoxia, 
after resection of the carotid chemoreceptors. The other patient 
presented cardiac valve disease from rheumatic fever.
The postoperative follow-up ranged from 3 months to 14 
years, averaging 5.1 years, with no recurrences and no mortality, 
but with the abovementioned morbidity.
DISCUSSION
The carotid body is a structure that measures around 2 x 3 x 5 
millimeters, located at the common carotid artery bifurcation, in 
the adventitia between the external and internal carotids. It con-
tains chemoreceptors that are sensitive to hypoxia, hypercapnia 
and acidosis, and aims to maintain the body’s homeostasis and 
blood pressure. As reported by Kapoor et al., this structure was 
first described by Von Haller in 1743.6
The incidence of this tumor is greater at higher altitudes, 
due to the chronic hypoxia.7 There have been several reports in 
the literature mentioning absence of significant predominance 
between the genders, although our series showed predomi-
nance of females (63.6%). These tumors are difficult to diag-
nose because of their rarity and few manifested symptoms. The 
paramount clinical characteristic is a pulsatile cervical mass. As 
reported in the literature, the diagnosis can be confused even 
with benign conditions, including congenital branchial cysts13 or 
other benign conditions. Thus, as pointed out in the literature, a 
pulsatile mass near the carotid bulb, in the absence of any sug-
gestion of metastatic disease, should raise the possible diagno-
sis of chemodectoma and should be followed by specific arterial 
imaging studies.
FNA was helpful for the diagnosis in the cases of four patients 
in our study. However, this procedure may be dangerous and per-
forming it is controversial because of the risk of bleeding.2
Ultrasonography and CT scans can be very helpful for the 
preoperative diagnosis and may show enlargement of the bifurca-
tion and hypervascularized tumors. Some authors have reported 
that ultrasonography with Doppler flowmetry can help surgeons 
in the initial approach.17 However, CT scans or magnetic reso-
nance imaging are better for identifying the dimensions and ana-
tomical correlations of the tumor.18 The main diagnostic tool is 
arterial studies such as contrast angiography, computed angioto-
mography or magnetic resonance angiography (MRA), thereby 
confirming or not confirming the suspected diagnosis. The MRA 
seems to be preferable nowadays.14
In the literature, the best treatment is considered to be sur-
gical, with dissection of the tumor in the sub-adventitial avas-
cular plane of the artery.12 Large tumors (Shamblin II and III) 
may require vascular procedures, including repairs, sutures and 
resections of the arterial segments.19 At times, it may be neces-
sary to sacrifice the external carotid artery, perform anastomo-
sis between the internal and common carotid arteries or under-
take vascular reconstruction with grafts.11-13,20,21 Some authors 
have described use of a stent inserted into the internal carotid 
artery before the surgery, in cases presenting as Shamblin III with 
complete involvement of this artery.22 Occurrences of technical 
complications in anastomoses between the common and internal 
carotid arteries after resection of the carotid body have also been 
reported in the literature. These cases evolved with several hema-
tomas and, in some cases, with stroke caused by deficits of cere-
bral irrigation.8,13,23 This complication did not occur in our series.
In patients with bilateral tumors, obviously, the proce-
dures should not be done at the same time, but spaced out one 
from another, especially because of possible vascular or cra-
nial nerve lesions.8 Conservative treatment should be reserved 
for patients who are not suitable for surgery, such as clinically 
unstable patients, extremely old patients or those with the cer-
tainty of stroke. Some authors have suggested that radiotherapy 
could be used, but this is not recommended by most institutions. 
Furthermore, studies have shown that this therapeutic method is 
ineffective in these tumors.3,24-28 
Embolization is another therapeutic method, usually done 
prior to the surgical procedure, as an attempt to decrease intra-
operative bleeding.21,29 However, this demands specialized skill 
and also has the risk of possible significant vascular complications 
Graph 2. Neurological sequelae according to Shamblin 
classification.
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and cranial nerve deficits. In our service, the patients were treated 
without preoperative embolization. In the literature, it is men-
tioned that vascular complications and cranial nerve deficits can 
occur in about 33% of the patients.1,11 A famous study at the Mayo 
Clinic evaluated patients’ complications compared between three 
periods of that institution’s surgical history. It was concluded that, 
despite the decreases in vascular complications and mortality over 
the course of time, through better diagnostic methods and surgi-
cal technologies or skills, the rate of neurological injuries was not 
statistically different between the three periods studied, spanning 
a total of fifty years.30 In our series, cranial nerve deficits occurred 
in two patients, involving the IX, X and XII pairs. We had another 
patient who evolved with sympathetic chain palsy. Power et al. 
demonstrated that preoperative embolization may have some 
benefits for the surgical approach, especially relating to surgical 
bleeding, but the patients that they followed up did not present 
any differences in definitive neurological sequelae.16
Although our series did not have any cases of malignant che-
modectoma, it is important to mention that the malignant poten-
tial has been reported to be around 2-6 % in the literature, most 
frequently with metastasis to regional lymph nodes.8,23 Some 
authors have prescribed chemotherapy for metastasized cases.31
Finally, although we did not have any cases of mortality, the 
literature mentions a mortality rate of less than 2%.1
CONCLUSIONS 
Complementary imaging study methods such as ultrasonography, 
computed tomography, magnetic resonance or, especially, arte-
riography need to be included in evaluations today, in order to analyze 
the involvement of the carotid artery and to program the surgical treat-
ment for carotid body tumors.
This study, in agreement with the literature, demonstrated 
that significant bleeding and neurological sequelae may occur, 
and that this risk increases according to the Shamblin classifica-
tion, particularly in Shamblin III patients. Even though preop-
erative embolization may be an important alternative, the com-
plications observed in treatment without previous embolization 
were similar.
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